PubRank

Marianne Amalric

Author PubWeight™ 21.30‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The subthalamic nucleus exerts opposite control on cocaine and 'natural' rewards. Nat Neurosci 2005 1.21
2 Enhanced food-related motivation after bilateral lesions of the subthalamic nucleus. J Neurosci 2002 1.15
3 Targeting group III metabotropic glutamate receptors produces complex behavioral effects in rodent models of Parkinson's disease. J Neurosci 2007 1.15
4 The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease. J Pharmacol Exp Ther 2011 1.14
5 Electrophysiological and behavioral evidence that modulation of metabotropic glutamate receptor 4 with a new agonist reverses experimental parkinsonism. FASEB J 2009 1.12
6 Excitotoxic lesions of the prelimbic-infralimbic areas of the rodent prefrontal cortex disrupt motor preparatory processes. Eur J Neurosci 2003 1.02
7 Synthesis and biological evaluation of 1-amino-2-phosphonomethylcyclopropanecarboxylic acids, new group III metabotropic glutamate receptor agonists. J Med Chem 2007 1.00
8 Chronic but not acute treatment with a metabotropic glutamate 5 receptor antagonist reverses the akinetic deficits in a rat model of parkinsonism. J Neurosci 2002 0.99
9 A novel selective metabotropic glutamate receptor 4 agonist reveals new possibilities for developing subtype selective ligands with therapeutic potential. FASEB J 2012 0.96
10 Spatial deficits in a mouse model of Parkinson disease. Psychopharmacology (Berl) 2007 0.95
11 Simultaneous blockade of adenosine A2A and metabotropic glutamate mGlu5 receptors increase their efficacy in reversing Parkinsonian deficits in rats. Neuropsychopharmacology 2004 0.94
12 Metabotropic glutamate 5 receptor blockade alleviates akinesia by normalizing activity of selective basal-ganglia structures in parkinsonian rats. J Neurosci 2003 0.93
13 High frequency stimulation of the subthalamic nucleus has beneficial antiparkinsonian effects on motor functions in rats, but less efficiency in a choice reaction time task. Eur J Neurosci 2003 0.93
14 Functional interaction between adenosine A2A and group III metabotropic glutamate receptors to reduce parkinsonian symptoms in rats. Neuropharmacology 2008 0.85
15 Dysfunction of the cortico-basal ganglia-cortical loop in a rat model of early parkinsonism is reversed by metabotropic glutamate receptor 5 antagonism. Eur J Neurosci 2005 0.85
16 Metabotropic glutamate receptors 5 blockade reverses spatial memory deficits in a mouse model of Parkinson's disease. Neuropsychopharmacology 2008 0.83
17 Contributions of dorsal striatal subregions to spatial alternation behavior. Learn Mem 2011 0.82
18 Functional interaction between mGlu 5 and NMDA receptors in a rat model of Parkinson's disease. Psychopharmacology (Berl) 2005 0.81
19 The dopamine agonist piribedil with L-DOPA improves attentional dysfunction: relevance for Parkinson's disease. J Pharmacol Exp Ther 2006 0.80
20 D1 and D2 dopamine receptors contribute to the locomotor response induced by Group II mGluRs activation in the rat nucleus accumbens. Pharmacol Biochem Behav 2002 0.79
21 Selective effects of partial striatal 6-OHDA lesions on information processing in the rat. Eur J Neurosci 2005 0.78
22 Kv4 channel blockade reduces motor and neuropsychiatric symptoms in rodent models of Parkinson's disease. Behav Pharmacol 2015 0.75
23 Dynamics of executive control and motor deficits in parkinsonian rats. J Neurosci 2011 0.75
24 Interaction between the mGlu receptors 5 antagonist, MPEP, and amphetamine on memory and motor functions in mice. Psychopharmacology (Berl) 2012 0.75